HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
基本信息
- 批准号:7008196
- 负责人:
- 金额:$ 26.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2008-01-31
- 项目状态:已结题
- 来源:
- 关键词:DNA directed RNA polymeraseaffinity chromatographychromatincofactorenzyme complexenzyme mechanismenzyme structuregenetic manipulationgenetic transcriptionhuman immunodeficiency virus 1peptidesposttranslational modificationsprotein purificationprotein structure functiontissue /cell culturetranscription factortransfectionvirus geneticsvirus proteinvirus replicationwestern blottings
项目摘要
DESCRIPTION (provided by applicant): The HIV-1-encoded Tat protein is a potent transcriptional activator that is essential for viral replication. The long-term objective of this proposal is to gain a better understanding of the control of HIV-1 gene expression by Tat and cellular factors at the molecular level. This study will focus on a novel RNA Pol II complex (Tat- SF) that efficiently mediates Tat-enhanced transcription (Tat function). Tat-SF contains P-TEFb, Spt5/Spt4, and Tat-SF1 and novel polypeptides, but none of the yeast coactivator SRB/MED-like proteins found associated with RNA Pol II holoenzyme. Notably, these Tat-SF cofactors can jointly complement the transcription initiation competent RNA Pol II holoenzyme for potent transcription elongation, reinitiation, and Tat transactivation, indicating that Tat-SF contains critical transcription factors. The mechanisms by which Tat-SF and RNA Pol II holoenzyme collectively mediate potent Tat-enhanced HIV-1 transcription are poorly understood. This proposal has three specific aims. The first will determine and compare the polypeptide composition of Tat-SF and Tat-SF cofactors derived from HeLa cytoplasm, nuclear extract, and nuclear pellet (chromatin). The second aim will examine the mechanisms by which Tat-SF cofactors mediate potent Tat-enhanced HIV-1 transcription. These studies will provide insights into synergisms of Tat-SF cofactors within themselves and with other transcription factors and protein modifications (e.g. phosphorylation, acetylation, methylation) for potent Tat activation. The third aim will specifically study the interplay of Tat-SF and the SRB/MED complex for efficient general transcription reinitiation and elongation. These experiments will include the detailed characterization of a potential SRB/MED complex-containing scaffold formed on the HIV- 1 promoter that could be utilized by Tat-SF for efficient transcription. The effects of Tat on Tat-SF- and RNA Pol II holoenzyme-mediated transcription elongation and re-initiation will also be examined. Collectively, these studies will identify novel factors and mechanisms that are important for single and multiple round of HIV-1 transcription. They will also establish a unique well-defined in vitro system for future elaboration of the link between HIV-1 transcription elongation and mRNA processing either on naked or chromatin DNA templates. Together, understanding Tat-enhanced HIV-1 transcription at the molecular level will be instrumental for future therapeutic antiviral strategies to block viral replication.
描述(由申请人提供):HIV-1 编码的 Tat 蛋白是一种有效的转录激活剂,对于病毒复制至关重要。该提案的长期目标是在分子水平上更好地了解 Tat 和细胞因子对 HIV-1 基因表达的控制。本研究将重点关注一种新型 RNA Pol II 复合物 (Tat-SF),该复合物可有效介导 Tat 增强转录(Tat 功能)。 Tat-SF 含有 P-TEFb、Spt5/Spt4 和 Tat-SF1 以及新的多肽,但没有发现与 RNA Pol II 全酶相关的酵母辅激活剂 SRB/MED 样蛋白。值得注意的是,这些 Tat-SF 辅因子可以共同补充转录起始活性 RNA Pol II 全酶,以实现有效的转录延伸、重新起始和 Tat 反式激活,表明 Tat-SF 含有关键的转录因子。 Tat-SF 和 RNA Pol II 全酶共同介导有效的 Tat 增强的 HIV-1 转录的机制尚不清楚。该提案具有三个具体目标。第一个将确定并比较来自 HeLa 细胞质、核提取物和核沉淀(染色质)的 Tat-SF 和 Tat-SF 辅因子的多肽组成。第二个目标是研究 Tat-SF 辅助因子介导有效 Tat 增强的 HIV-1 转录的机制。这些研究将深入了解 Tat-SF 辅因子本身以及与其他转录因子和蛋白质修饰(例如磷酸化、乙酰化、甲基化)的协同作用,以有效激活 Tat。第三个目标将专门研究 Tat-SF 和 SRB/MED 复合物的相互作用,以实现有效的一般转录重新启动和延伸。这些实验将包括在 HIV-1 启动子上形成的潜在 SRB/MED 复合物支架的详细表征,Tat-SF 可利用该支架进行有效转录。还将检查 Tat 对 Tat-SF- 和 RNA Pol II 全酶介导的转录延伸和重新启动的影响。总的来说,这些研究将确定对单轮和多轮 HIV-1 转录很重要的新因素和机制。他们还将建立一个独特的、明确的体外系统,以便将来在裸DNA或染色质DNA模板上详细阐述HIV-1转录延伸和mRNA加工之间的联系。总之,在分子水平上了解 Tat 增强的 HIV-1 转录将有助于未来阻止病毒复制的治疗性抗病毒策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAMILO A PARADA其他文献
CAMILO A PARADA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAMILO A PARADA', 18)}}的其他基金
HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
- 批准号:
6892475 - 财政年份:2005
- 资助金额:
$ 26.29万 - 项目类别:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
- 批准号:
7102120 - 财政年份:2005
- 资助金额:
$ 26.29万 - 项目类别:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
- 批准号:
7174181 - 财政年份:2005
- 资助金额:
$ 26.29万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 26.29万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 26.29万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 26.29万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 26.29万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 26.29万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 26.29万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 26.29万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 26.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 26.29万 - 项目类别:
Collaborative Research and Development Grants